ISSN: 0975-0851
Statistical considerations in biosimilar assessment using biosimilarity index
In-vitro Release of Rapamycin from a Thermosensitive Polymer for the Inhibition of Vascular Smooth Muscle Cell Proliferation
View More »
Journal of Bioequivalence & Bioavailability received 4890 citations as per Google Scholar report
Research Article
An Open Label, Balanced, Randomized, Two Treatments, Two Sequences, Four Periods, Fully Replicate, Crossover, Bioequivalence Study of Abiraterone Acetate 250 mg Tablets of Abbott Laboratories De Colombia Versus ZYTIGA® (Abiraterone Acetate) 250 mg Tablets of Janssen Biotech, Inc. Under Fasting Condition in Healthy Subjects
DOI: 10.35248/0975-0851.22.S8.001
Bioequivalence Study of Two Ticagrelor 90 mg Tablets in Healthy Thai Volunteers under Fasting Conditions
DOI: 10.35248/0975-0851.22.S8.002
Single-Dose, Randomized, Open-Label, Two-Way, Crossover Bioequivalence Studies of two formulations of 500-mg Delayed-Release Valproate semisodium Tablets in Healthy Mexican Population Under Fasted and Fed Conditions
DOI: 10.35248/0975-0851.22.S8.003
Opinion Article
Evaluation and Impact of Cytarabine High Dose Interactions for Patients with Acute Leukemia
DOI: 10.35248/0975-0851.22.S8.004
Commentary
Mechanism of Iron Deficiency Anemia Severity Associated with Ferrous Sulfate Drugs
DOI: 10.35248/0975-0851.22.S8.005